Market closed

Moderna/MRNA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Moderna

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Ticker

MRNA
Trading on

Industry

Biotechnology

Employees

5,600

Moderna Metrics

BasicAdvanced
$23B
Market cap
-
P/E ratio
-$15.36
EPS
1.66
Beta
-
Dividend rate
$23B
1.66
$170.47
$59.62
5.6M
4.088
3.661
10.622
10.835
-92.70%
-15.42%
-40.94%
4.554
1.97
1.97
-5.779
-52.60%
-602.49%
-10.39%
21.94%

What the Analysts think about Moderna

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Moderna stock.

Moderna Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Moderna Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy MRNA

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Moderna stock?

Moderna (MRNA) has a market cap of $23B as of October 06, 2024.

What is the P/E ratio for Moderna stock?

The price to earnings (P/E) ratio for Moderna (MRNA) stock is 0 as of October 06, 2024.

Does Moderna stock pay dividends?

No, Moderna (MRNA) stock does not pay dividends to its shareholders as of October 06, 2024.

When is the next Moderna dividend payment date?

Moderna (MRNA) stock does not pay dividends to its shareholders.

What is the beta indicator for Moderna?

Moderna (MRNA) has a beta rating of 1.66. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.